Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2007-09-17 Regulatory Filings
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Regulatory Filings 2007
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, XTL Biopharmaceuticals Ltd., with the SEC. It reports on a presentation of new pre-clinical data regarding hepatitis C inhibitors at an international scientific conference. The content is primarily a press release about scientific and clinical development progress, not a financial report or earnings release. It does not contain financial statements or detailed financial analysis. The document is not an announcement of voting results, management changes, or legal proceedings. It is a regulatory filing providing material information to investors but does not fit into categories like Annual Report, Interim Report, Earnings Release, or Investor Presentation. Given the nature of Form 6-K filings and the content, the best classification is Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories. The document length (8916 characters) and content support this classification with high confidence.
2007-09-17 English
Immediate Report
Regulatory Filings Classification · 95% confidence The document is a press release announcing the presentation of new pre-clinical compounds for hepatitis C at an international scientific conference. It contains no financial data, no regulatory filing references, no voting results, no management or board changes, no earnings or interim report data, and no detailed financial or governance information. It is a corporate announcement about scientific and product development progress, not a formal financial or regulatory filing. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. The closest fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2007-09-17 Hebrew (modern)
Immediate Report
Report Publication Announcement Classification · 95% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority and the Tel Aviv Stock Exchange. The key content states: 'Attached hereto is a report on *THE PRESENTATION OF A NEW CLASS OF HIGHLY POTENT SMALL MOLECULE INHIBITORS OF HEPATITIS C AFFECTING THE NS5A TARGET AT AN INTERNATIONAL SCIENTIFIC CONFERENCE*'. This structure—a brief regulatory filing announcing the attachment or availability of another document (a presentation or scientific update)—fits the definition of a Report Publication Announcement (RPA) or potentially a Regulatory Filing (RNS). Since the content specifically relates to a scientific presentation being made public, and the document itself is short and serves primarily to announce the attached PDF, RPA is the most precise fit, as it signals the publication of specific material. It is not the presentation itself (IP), nor a general earnings release (ER), nor a full annual report (10-K). Given the nature of announcing a scientific presentation, RPA is chosen over the general RNS fallback.
2007-09-17 English
Regulatory Filings 2007
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, XTL Biopharmaceuticals Ltd., with the SEC. It announces a conference call to discuss the initiation of a Phase IIb clinical trial for a drug. The document includes details about the call, participants, and replay information. It does not contain financial statements or detailed financial analysis. The length is 3786 characters, which is relatively short and primarily an announcement of an event (conference call). This matches the characteristics of a Call Transcript announcement or a conference call notice. However, since it is a notice of an upcoming call rather than a transcript, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other categories like Earnings Release or Call Transcript. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2007-09-11 English
Other Report or Announcement
Regulatory Filings Classification · 95% confidence The document is a short announcement about a conference call to discuss a clinical trial. It includes details on the call time, participants, and replay information. There is no financial data, no detailed presentation, or transcript of the call itself. The document is essentially a notice or reminder about the call, not the call transcript or a financial report. Given the content and length (2225 characters), this fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other categories like Call Transcript (CT) or Investor Presentation (IP).
2007-09-11 Hebrew (modern)
Other Report or Announcement
Report Publication Announcement Classification · 98% confidence The document is very short (1627 characters) and explicitly states that an attached file, named 'ConferenceCallReminder91107Final_isa.pdf', is a 'Bicifadine Trial - Conference Call - Reminder'. According to Rule 2 (The 'MENU VS MEAL' RULE), a short document announcing the publication or attachment of another report/material, rather than being the full content itself, should be classified as a Report Publication Announcement (RPA). Although it relates to a conference call, the document itself is a reminder/announcement of that event, not the transcript (CT).
2007-09-11 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.